Adding evolocumab to lipid-lowering therapy reduces all-cause mortality in high-risk patients without a history of myocardial infarction or stroke.
Gossamer Bio has submitted a New Drug Application to the FDA seeking approval of seralutinib for pulmonary arterial hypertension (PAH).
Among critically ill patients with acute kidney injury, intermittent hemodialysis as an initial treatment is not noninferior to CRRT.
FibroScan-aspartate aminotransferase may offer the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis.
New guidelines for menopause treatment focus on hormone therapy and managing symptoms like hot flashes, sleep trouble, and depression.
GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results